Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-010044
Filing Date
2019-05-15
Accepted
2019-05-15 15:54:04
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q innv20190331_10q.htm 10-Q 721406
2 EXHIBIT 31.1 ex_139941.htm EX-31.1 13440
3 EXHIBIT 31.2 ex_139942.htm EX-31.2 13637
4 EXHIBIT 32.1 ex_139943.htm EX-32.1 5184
  Complete submission text file 0001437749-19-010044.txt   4806497

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT innv-20190331.xml EX-101.INS 941979
6 XBRL TAXONOMY EXTENSION SCHEMA innv-20190331.xsd EX-101.SCH 59368
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE innv-20190331_cal.xml EX-101.CAL 43706
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE innv-20190331_def.xml EX-101.DEF 378349
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE innv-20190331_lab.xml EX-101.LAB 355560
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE innv-20190331_pre.xml EX-101.PRE 401967
Mailing Address 8845 REHCO ROAD SAN DIEGO CA 92121
Business Address 8845 REHCO ROAD SAN DIEGO CA 92121 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52991 | Film No.: 19827751
SIC: 2834 Pharmaceutical Preparations